The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tuberculosis Vaccine for Vhildren Market Research Report 2025
Synopsis
Vaccines to prevent tuberculosis in children.
The global Tuberculosis Vaccine for Vhildren market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tuberculosis Vaccine for Vhildren is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tuberculosis Vaccine for Vhildren is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tuberculosis Vaccine for Vhildren include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL and Shaanxi Pharmaceutical Holding Group Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccine for Vhildren, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccine for Vhildren.
Report Scope
The Tuberculosis Vaccine for Vhildren market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Vaccine for Vhildren market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Vaccine for Vhildren manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Shaanxi Pharmaceutical Holding Group Biological Products
Segment by Type
0.5ml
1ml
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tuberculosis Vaccine for Vhildren manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tuberculosis Vaccine for Vhildren in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vaccines to prevent tuberculosis in children.
The global Tuberculosis Vaccine for Vhildren market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tuberculosis Vaccine for Vhildren is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tuberculosis Vaccine for Vhildren is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tuberculosis Vaccine for Vhildren include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL and Shaanxi Pharmaceutical Holding Group Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccine for Vhildren, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccine for Vhildren.
Report Scope
The Tuberculosis Vaccine for Vhildren market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Vaccine for Vhildren market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Vaccine for Vhildren manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Shaanxi Pharmaceutical Holding Group Biological Products
Segment by Type
0.5ml
1ml
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tuberculosis Vaccine for Vhildren manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tuberculosis Vaccine for Vhildren in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Tuberculosis Vaccine for Vhildren Market Overview
1.1 Product Overview and Scope of Tuberculosis Vaccine for Vhildren
1.2 Tuberculosis Vaccine for Vhildren Segment by Type
1.2.1 Global Tuberculosis Vaccine for Vhildren Market Value Comparison by Type (2024-2030)
1.2.2 0.5ml
1.2.3 1ml
1.2.4 Others
1.3 Tuberculosis Vaccine for Vhildren Segment by Application
1.3.1 Global Tuberculosis Vaccine for Vhildren Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Tuberculosis Vaccine for Vhildren Market Size Estimates and Forecasts
1.4.1 Global Tuberculosis Vaccine for Vhildren Revenue 2019-2030
1.4.2 Global Tuberculosis Vaccine for Vhildren Sales 2019-2030
1.4.3 Global Tuberculosis Vaccine for Vhildren Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tuberculosis Vaccine for Vhildren Market Competition by Manufacturers
2.1 Global Tuberculosis Vaccine for Vhildren Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tuberculosis Vaccine for Vhildren Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tuberculosis Vaccine for Vhildren Average Price by Manufacturers (2019-2024)
2.4 Global Tuberculosis Vaccine for Vhildren Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tuberculosis Vaccine for Vhildren, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tuberculosis Vaccine for Vhildren, Product Type & Application
2.7 Tuberculosis Vaccine for Vhildren Market Competitive Situation and Trends
2.7.1 Tuberculosis Vaccine for Vhildren Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tuberculosis Vaccine for Vhildren Players Market Share by Revenue
2.7.3 Global Tuberculosis Vaccine for Vhildren Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tuberculosis Vaccine for Vhildren Retrospective Market Scenario by Region
3.1 Global Tuberculosis Vaccine for Vhildren Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tuberculosis Vaccine for Vhildren Global Tuberculosis Vaccine for Vhildren Sales by Region: 2019-2030
3.2.1 Global Tuberculosis Vaccine for Vhildren Sales by Region: 2019-2024
3.2.2 Global Tuberculosis Vaccine for Vhildren Sales by Region: 2025-2030
3.3 Global Tuberculosis Vaccine for Vhildren Global Tuberculosis Vaccine for Vhildren Revenue by Region: 2019-2030
3.3.1 Global Tuberculosis Vaccine for Vhildren Revenue by Region: 2019-2024
3.3.2 Global Tuberculosis Vaccine for Vhildren Revenue by Region: 2025-2030
3.4 North America Tuberculosis Vaccine for Vhildren Market Facts & Figures by Country
3.4.1 North America Tuberculosis Vaccine for Vhildren Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tuberculosis Vaccine for Vhildren Sales by Country (2019-2030)
3.4.3 North America Tuberculosis Vaccine for Vhildren Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tuberculosis Vaccine for Vhildren Market Facts & Figures by Country
3.5.1 Europe Tuberculosis Vaccine for Vhildren Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tuberculosis Vaccine for Vhildren Sales by Country (2019-2030)
3.5.3 Europe Tuberculosis Vaccine for Vhildren Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Tuberculosis Vaccine for Vhildren Market Facts & Figures by Country
3.6.1 Asia Pacific Tuberculosis Vaccine for Vhildren Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tuberculosis Vaccine for Vhildren Sales by Country (2019-2030)
3.6.3 Asia Pacific Tuberculosis Vaccine for Vhildren Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Tuberculosis Vaccine for Vhildren Market Facts & Figures by Country
3.7.1 Latin America Tuberculosis Vaccine for Vhildren Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tuberculosis Vaccine for Vhildren Sales by Country (2019-2030)
3.7.3 Latin America Tuberculosis Vaccine for Vhildren Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tuberculosis Vaccine for Vhildren Market Facts & Figures by Country
3.8.1 Middle East and Africa Tuberculosis Vaccine for Vhildren Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tuberculosis Vaccine for Vhildren Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tuberculosis Vaccine for Vhildren Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tuberculosis Vaccine for Vhildren Sales by Type (2019-2030)
4.1.1 Global Tuberculosis Vaccine for Vhildren Sales by Type (2019-2024)
4.1.2 Global Tuberculosis Vaccine for Vhildren Sales by Type (2025-2030)
4.1.3 Global Tuberculosis Vaccine for Vhildren Sales Market Share by Type (2019-2030)
4.2 Global Tuberculosis Vaccine for Vhildren Revenue by Type (2019-2030)
4.2.1 Global Tuberculosis Vaccine for Vhildren Revenue by Type (2019-2024)
4.2.2 Global Tuberculosis Vaccine for Vhildren Revenue by Type (2025-2030)
4.2.3 Global Tuberculosis Vaccine for Vhildren Revenue Market Share by Type (2019-2030)
4.3 Global Tuberculosis Vaccine for Vhildren Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tuberculosis Vaccine for Vhildren Sales by Application (2019-2030)
5.1.1 Global Tuberculosis Vaccine for Vhildren Sales by Application (2019-2024)
5.1.2 Global Tuberculosis Vaccine for Vhildren Sales by Application (2025-2030)
5.1.3 Global Tuberculosis Vaccine for Vhildren Sales Market Share by Application (2019-2030)
5.2 Global Tuberculosis Vaccine for Vhildren Revenue by Application (2019-2030)
5.2.1 Global Tuberculosis Vaccine for Vhildren Revenue by Application (2019-2024)
5.2.2 Global Tuberculosis Vaccine for Vhildren Revenue by Application (2025-2030)
5.2.3 Global Tuberculosis Vaccine for Vhildren Revenue Market Share by Application (2019-2030)
5.3 Global Tuberculosis Vaccine for Vhildren Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Tuberculosis Vaccine for Vhildren Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Tuberculosis Vaccine for Vhildren Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Tuberculosis Vaccine for Vhildren Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur Tuberculosis Vaccine for Vhildren Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab Tuberculosis Vaccine for Vhildren Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Japan BCG Lab Tuberculosis Vaccine for Vhildren Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 China National Biotec
6.4.1 China National Biotec Corporation Information
6.4.2 China National Biotec Description and Business Overview
6.4.3 China National Biotec Tuberculosis Vaccine for Vhildren Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China National Biotec Tuberculosis Vaccine for Vhildren Product Portfolio
6.4.5 China National Biotec Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Tuberculosis Vaccine for Vhildren Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute of India Tuberculosis Vaccine for Vhildren Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Intervax
6.6.1 Intervax Corporation Information
6.6.2 Intervax Description and Business Overview
6.6.3 Intervax Tuberculosis Vaccine for Vhildren Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Intervax Tuberculosis Vaccine for Vhildren Product Portfolio
6.6.5 Intervax Recent Developments/Updates
6.7 GSBPL
6.6.1 GSBPL Corporation Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL Tuberculosis Vaccine for Vhildren Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSBPL Tuberculosis Vaccine for Vhildren Product Portfolio
6.7.5 GSBPL Recent Developments/Updates
6.8 Shaanxi Pharmaceutical Holding Group Biological Products
6.8.1 Shaanxi Pharmaceutical Holding Group Biological Products Corporation Information
6.8.2 Shaanxi Pharmaceutical Holding Group Biological Products Description and Business Overview
6.8.3 Shaanxi Pharmaceutical Holding Group Biological Products Tuberculosis Vaccine for Vhildren Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shaanxi Pharmaceutical Holding Group Biological Products Tuberculosis Vaccine for Vhildren Product Portfolio
6.8.5 Shaanxi Pharmaceutical Holding Group Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tuberculosis Vaccine for Vhildren Industry Chain Analysis
7.2 Tuberculosis Vaccine for Vhildren Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tuberculosis Vaccine for Vhildren Production Mode & Process
7.4 Tuberculosis Vaccine for Vhildren Sales and Marketing
7.4.1 Tuberculosis Vaccine for Vhildren Sales Channels
7.4.2 Tuberculosis Vaccine for Vhildren Distributors
7.5 Tuberculosis Vaccine for Vhildren Customers
8 Tuberculosis Vaccine for Vhildren Market Dynamics
8.1 Tuberculosis Vaccine for Vhildren Industry Trends
8.2 Tuberculosis Vaccine for Vhildren Market Drivers
8.3 Tuberculosis Vaccine for Vhildren Market Challenges
8.4 Tuberculosis Vaccine for Vhildren Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Tuberculosis Vaccine for Vhildren Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tuberculosis Vaccine for Vhildren Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Tuberculosis Vaccine for Vhildren Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tuberculosis Vaccine for Vhildren Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Tuberculosis Vaccine for Vhildren Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tuberculosis Vaccine for Vhildren Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tuberculosis Vaccine for Vhildren Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tuberculosis Vaccine for Vhildren Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tuberculosis Vaccine for Vhildren, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tuberculosis Vaccine for Vhildren, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tuberculosis Vaccine for Vhildren, Product Type & Application
Table 12. Global Key Manufacturers of Tuberculosis Vaccine for Vhildren, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tuberculosis Vaccine for Vhildren by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccine for Vhildren as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tuberculosis Vaccine for Vhildren Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tuberculosis Vaccine for Vhildren Sales by Region (2019-2024) & (K Units)
Table 18. Global Tuberculosis Vaccine for Vhildren Sales Market Share by Region (2019-2024)
Table 19. Global Tuberculosis Vaccine for Vhildren Sales by Region (2025-2030) & (K Units)
Table 20. Global Tuberculosis Vaccine for Vhildren Sales Market Share by Region (2025-2030)
Table 21. Global Tuberculosis Vaccine for Vhildren Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tuberculosis Vaccine for Vhildren Revenue Market Share by Region (2019-2024)
Table 23. Global Tuberculosis Vaccine for Vhildren Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tuberculosis Vaccine for Vhildren Revenue Market Share by Region (2025-2030)
Table 25. North America Tuberculosis Vaccine for Vhildren Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tuberculosis Vaccine for Vhildren Sales by Country (2019-2024) & (K Units)
Table 27. North America Tuberculosis Vaccine for Vhildren Sales by Country (2025-2030) & (K Units)
Table 28. North America Tuberculosis Vaccine for Vhildren Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tuberculosis Vaccine for Vhildren Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tuberculosis Vaccine for Vhildren Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tuberculosis Vaccine for Vhildren Sales by Country (2019-2024) & (K Units)
Table 32. Europe Tuberculosis Vaccine for Vhildren Sales by Country (2025-2030) & (K Units)
Table 33. Europe Tuberculosis Vaccine for Vhildren Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tuberculosis Vaccine for Vhildren Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tuberculosis Vaccine for Vhildren Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tuberculosis Vaccine for Vhildren Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Tuberculosis Vaccine for Vhildren Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Tuberculosis Vaccine for Vhildren Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tuberculosis Vaccine for Vhildren Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tuberculosis Vaccine for Vhildren Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tuberculosis Vaccine for Vhildren Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Tuberculosis Vaccine for Vhildren Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Tuberculosis Vaccine for Vhildren Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tuberculosis Vaccine for Vhildren Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Tuberculosis Vaccine for Vhildren Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Tuberculosis Vaccine for Vhildren Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Tuberculosis Vaccine for Vhildren Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Tuberculosis Vaccine for Vhildren Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Tuberculosis Vaccine for Vhildren Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tuberculosis Vaccine for Vhildren Sales (K Units) by Type (2019-2024)
Table 51. Global Tuberculosis Vaccine for Vhildren Sales (K Units) by Type (2025-2030)
Table 52. Global Tuberculosis Vaccine for Vhildren Sales Market Share by Type (2019-2024)
Table 53. Global Tuberculosis Vaccine for Vhildren Sales Market Share by Type (2025-2030)
Table 54. Global Tuberculosis Vaccine for Vhildren Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tuberculosis Vaccine for Vhildren Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tuberculosis Vaccine for Vhildren Revenue Market Share by Type (2019-2024)
Table 57. Global Tuberculosis Vaccine for Vhildren Revenue Market Share by Type (2025-2030)
Table 58. Global Tuberculosis Vaccine for Vhildren Price (US$/Unit) by Type (2019-2024)
Table 59. Global Tuberculosis Vaccine for Vhildren Price (US$/Unit) by Type (2025-2030)
Table 60. Global Tuberculosis Vaccine for Vhildren Sales (K Units) by Application (2019-2024)
Table 61. Global Tuberculosis Vaccine for Vhildren Sales (K Units) by Application (2025-2030)
Table 62. Global Tuberculosis Vaccine for Vhildren Sales Market Share by Application (2019-2024)
Table 63. Global Tuberculosis Vaccine for Vhildren Sales Market Share by Application (2025-2030)
Table 64. Global Tuberculosis Vaccine for Vhildren Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tuberculosis Vaccine for Vhildren Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tuberculosis Vaccine for Vhildren Revenue Market Share by Application (2019-2024)
Table 67. Global Tuberculosis Vaccine for Vhildren Revenue Market Share by Application (2025-2030)
Table 68. Global Tuberculosis Vaccine for Vhildren Price (US$/Unit) by Application (2019-2024)
Table 69. Global Tuberculosis Vaccine for Vhildren Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Tuberculosis Vaccine for Vhildren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck Tuberculosis Vaccine for Vhildren Product
Table 74. Merck Recent Developments/Updates
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Tuberculosis Vaccine for Vhildren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Pasteur Tuberculosis Vaccine for Vhildren Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. Japan BCG Lab Corporation Information
Table 81. Japan BCG Lab Description and Business Overview
Table 82. Japan BCG Lab Tuberculosis Vaccine for Vhildren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Japan BCG Lab Tuberculosis Vaccine for Vhildren Product
Table 84. Japan BCG Lab Recent Developments/Updates
Table 85. China National Biotec Corporation Information
Table 86. China National Biotec Description and Business Overview
Table 87. China National Biotec Tuberculosis Vaccine for Vhildren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. China National Biotec Tuberculosis Vaccine for Vhildren Product
Table 89. China National Biotec Recent Developments/Updates
Table 90. Serum Institute of India Corporation Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India Tuberculosis Vaccine for Vhildren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Serum Institute of India Tuberculosis Vaccine for Vhildren Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. Intervax Corporation Information
Table 96. Intervax Description and Business Overview
Table 97. Intervax Tuberculosis Vaccine for Vhildren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Intervax Tuberculosis Vaccine for Vhildren Product
Table 99. Intervax Recent Developments/Updates
Table 100. GSBPL Corporation Information
Table 101. GSBPL Description and Business Overview
Table 102. GSBPL Tuberculosis Vaccine for Vhildren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. GSBPL Tuberculosis Vaccine for Vhildren Product
Table 104. GSBPL Recent Developments/Updates
Table 105. Shaanxi Pharmaceutical Holding Group Biological Products Corporation Information
Table 106. Shaanxi Pharmaceutical Holding Group Biological Products Description and Business Overview
Table 107. Shaanxi Pharmaceutical Holding Group Biological Products Tuberculosis Vaccine for Vhildren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Shaanxi Pharmaceutical Holding Group Biological Products Tuberculosis Vaccine for Vhildren Product
Table 109. Shaanxi Pharmaceutical Holding Group Biological Products Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Tuberculosis Vaccine for Vhildren Distributors List
Table 113. Tuberculosis Vaccine for Vhildren Customers List
Table 114. Tuberculosis Vaccine for Vhildren Market Trends
Table 115. Tuberculosis Vaccine for Vhildren Market Drivers
Table 116. Tuberculosis Vaccine for Vhildren Market Challenges
Table 117. Tuberculosis Vaccine for Vhildren Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tuberculosis Vaccine for Vhildren
Figure 2. Global Tuberculosis Vaccine for Vhildren Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tuberculosis Vaccine for Vhildren Market Share by Type in 2023 & 2030
Figure 4. 0.5ml Product Picture
Figure 5. 1ml Product Picture
Figure 6. Others Product Picture
Figure 7. Global Tuberculosis Vaccine for Vhildren Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Tuberculosis Vaccine for Vhildren Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Tuberculosis Vaccine for Vhildren Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Tuberculosis Vaccine for Vhildren Market Size (2019-2030) & (US$ Million)
Figure 14. Global Tuberculosis Vaccine for Vhildren Sales (2019-2030) & (K Units)
Figure 15. Global Tuberculosis Vaccine for Vhildren Average Price (US$/Unit) & (2019-2030)
Figure 16. Tuberculosis Vaccine for Vhildren Report Years Considered
Figure 17. Tuberculosis Vaccine for Vhildren Sales Share by Manufacturers in 2023
Figure 18. Global Tuberculosis Vaccine for Vhildren Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Tuberculosis Vaccine for Vhildren Players: Market Share by Revenue in 2023
Figure 20. Tuberculosis Vaccine for Vhildren Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Tuberculosis Vaccine for Vhildren Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Tuberculosis Vaccine for Vhildren Sales Market Share by Country (2019-2030)
Figure 23. North America Tuberculosis Vaccine for Vhildren Revenue Market Share by Country (2019-2030)
Figure 24. United States Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Tuberculosis Vaccine for Vhildren Sales Market Share by Country (2019-2030)
Figure 27. Europe Tuberculosis Vaccine for Vhildren Revenue Market Share by Country (2019-2030)
Figure 28. Germany Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Netherlands Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Tuberculosis Vaccine for Vhildren Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Tuberculosis Vaccine for Vhildren Revenue Market Share by Region (2019-2030)
Figure 35. China Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Tuberculosis Vaccine for Vhildren Sales Market Share by Country (2019-2030)
Figure 43. Latin America Tuberculosis Vaccine for Vhildren Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Tuberculosis Vaccine for Vhildren Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Tuberculosis Vaccine for Vhildren Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Tuberculosis Vaccine for Vhildren Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Tuberculosis Vaccine for Vhildren by Type (2019-2030)
Figure 53. Global Revenue Market Share of Tuberculosis Vaccine for Vhildren by Type (2019-2030)
Figure 54. Global Tuberculosis Vaccine for Vhildren Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Tuberculosis Vaccine for Vhildren by Application (2019-2030)
Figure 56. Global Revenue Market Share of Tuberculosis Vaccine for Vhildren by Application (2019-2030)
Figure 57. Global Tuberculosis Vaccine for Vhildren Price (US$/Unit) by Application (2019-2030)
Figure 58. Tuberculosis Vaccine for Vhildren Value Chain
Figure 59. Tuberculosis Vaccine for Vhildren Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
